A study on the effectiveness and safety of interventional embolization using drug-loaded microspheres in combination with sorafenib and envafolimab for intermediate and advanced renal cell carcinoma
Drug-loaded microsphere interventional embolization combined with sorafenib and envafolimab has certain efficacy and acceptable safety in treating intermediate and late-stage renal tumor, providing a new treatment option for patients with renal cell carcinoma.
Authors
- Yapeng Guo (ORCID: https://orcid.org/0000-0002-0041-425X)
- Yanfeng Shen (ORCID: https://orcid.org/0000-0003-3635-660X)
- Hangwen Guo
- Xin You (ORCID: https://orcid.org/0000-0002-7272-0061)
- Xiaoting Duan (ORCID: https://orcid.org/0000-0002-3281-6253)
- Yingying Zhang (ORCID: https://orcid.org/0000-0003-3772-3942)
- Shuai Li (ORCID: https://orcid.org/0000-0003-1107-6775)
- Xue‐Hui Zhang (ORCID: https://orcid.org/0000-0002-0958-057X)
- Xianming Liu (ORCID: https://orcid.org/0000-0001-7752-1136)
- Guiying Li (ORCID: https://orcid.org/0000-0002-7910-5387)
- Cheng Chen (ORCID: https://orcid.org/0000-0003-4227-6796)
- Suhua Zhang (ORCID: https://orcid.org/0000-0003-2033-473X)
- Shuyan Zhang (ORCID: https://orcid.org/0009-0004-3157-2818)
- Yanhong Ma
- Na Su (ORCID: https://orcid.org/0000-0003-0499-720X)
- Zhiwei Zhang (ORCID: https://orcid.org/0009-0006-6510-4670)
Institutions
- Hebei University of Engineering (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-29
- DOI
- https://doi.org/10.3389/fonc.2025.1558410
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00